论文信息 - 229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer - 字舞流文

229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer

D. Maloney | M. Borad | T. Welling | S. Kopetz | A. Kamb | J. Hsin | J. Molina | A. Mardiros | D. Simeone | F. Locke | W. Go | M. Sandberg | K. Kirtane | M. Morelli | Xueyin Wang | D. Nampe | M. McElvain | Wen-Hua Lee | Sanam Shafaattalab | J. Welch | E. Garon | Han Xu | Aaron D. Martin | L. Wong | Sara Martire | G. Gabrelow | E. Ng | J. Randolph Hecht | Fernando A Fisher | Yuta Ando | Chuck Z Li | Edwin Liu | David Ju | Sandip Patel | Alexandre Zampieri